# Revision to Restrictions on Shipment or Use for Human Blood and Blood Components Exceptions; Technical Amendment
> **Food and Drug Administration** · Final rule; technical amendment. · Published 2021-09-07 · 86 FR 49922
## Document
- **Document number:** 2021-19220
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 86 FR 49922
- **CFR reference:** 21 CFR 610
- **Publication date:** 2021-09-07
- **HHS docket:** Docket No. FDA-2021-N-0011
## Abstract

The Food and Drug Administration (FDA or we) is amending the biologics regulation to improve clarity and revise an incorrect citation. This action is being taken to ensure the accuracy and clarity of the biologics regulation.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2021/09/07/2021-19220/revision-to-restrictions-on-shipment-or-use-for-human-blood-and-blood-components-exceptions)
---
*AI Analytics · CC0 1.0*